Impaired insulin (InsR) and insulin growth factor receptor (IGF-1R) signaling via pAkt/Akt has been linked to cognitive decline in normal aging, as well as AD (O’Neill, 2013; Akintola and van Heemst, 2015; Kullmann et al., 2016). This evidence concerns the gene AKT1 and Alzheimer disease.